Saluda Medicine, which is behind the Evoke spinal cord stimulation system, received a $150 million equity financing round, the company said April 13.
The funding round was led by Wellington Management, according to a news release. The proceeeds will be used to push the commercial launch of Evoke.
The company also redomiciled as Saluda Medical Inc., a Delaware company. the release said.